Open-label, Randomised, Drug Interaction Study of Pyramax (Pyronaridine Artesunate) and the Protease Inhibitor Ritonavir in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 18 Mar 2011
At a glance
- Drugs Artesunate/pyronaridine (Primary) ; Ritonavir (Primary)
- Indications Falciparum malaria; HIV infections; Vivax malaria
- Focus Pharmacokinetics
- 18 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Jul 2010 New trial record